MedInvest
Biotech & Pharma
Investor Conference

ABOUT THE MEDINVEST BIOTECH & PHARMA INVESTOR CONFERENCE 

 

The upcoming meeting of the MedInvest Biotech & Pharma Investor Conference will be held in Palo Alto, CA on September 24-25, 2025. 

 

The conference will feature two days of company presentations, panel discussions, and keynote talks. Both in-person and virtual meetings will be taking place during the two days of the conference. The partnering system will be open for communications for one full month.

 

The presenting companies are developing and/or commercializing technologies across a broad spectrum of indications, including oncology, immunology, neurology, cardiology, diabetes, infectious diseases, pulmonary diseases, autoimmune diseases, respiratory diseases, urology, endocrinology, dermatology, pain management, and many others.

 

The attendees are active investors in the pharma, biotech, and other life science companies.  The event will also feature talks from industry key opinion leaders, investor panel discussions, and insightful conversations with the National Institutes of Health on partnering, facilitating collaborations, licensing and technology analysis and marketing.

​

The National Institutes of Health and Cooley are the Presenting Partners. MedInvest Investor Conference Series sponsors and hosts have included Cooley, Wilson Sonsini, Goodwin, McDermott Will & Emery, Fenwick, Perkins Coie, O'Melveny, Venable, Freemind Consultants, Torreya Partners, the NIH and NCI, and Marcum.

 

Join the leading life sciences and healthcare venture capitalists, family offices, lawyers, pharma executives, private and public biotech and pharmaceuticals companies and foundations for a discussion on trends, opportunities, and risks in life science investing.